MedPath

VIGADRONE

These highlights do not include all the information needed to use VIGA DRONE FOR ORAL SOLUTION safely and effectively. See full prescribing information for VIGADRONE FOR ORAL SOLUTION . VIGADRONE ( vigabatrin ) powder for oral solution Initial U.S. Approval: 2009

Approved
Approval ID

5e5e7554-d0f4-47f7-a434-cc5ca5a9826f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 17, 2020

Manufacturers
FDA

Upsher-Smith Laboratories, LLC

DUNS: 079111820

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

vigabatrin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0245-0556
Application NumberANDA210196
Product Classification
M
Marketing Category
C73584
G
Generic Name
vigabatrin
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 24, 2020
FDA Product Classification

INGREDIENTS (1)

VIGABATRINActive
Quantity: 50 mg in 1 mL
Code: GR120KRT6K
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VIGADRONE - FDA Drug Approval Details